Expression of small, therapeutic RNAs in human cell nuclei (original) (raw)
- Paper
- Published: 01 January 1997
- AJ Krikos1,
- SXL Li2,
- E Bertrand3,
- NS Lee3,
- L Giver4,
- A Ellington4,
- JA Zaia2,
- JJ Rossi3 &
- …
- DR Engelke1
Gene Therapy volume 4, pages 45–54 (1997)Cite this article
- 2665 Accesses
- 9 Altmetric
- Metrics details
Abstract
Effective intracellular expression of small RNA therapeutics depends on a number of factors. The RNA, whether antisense, ribozyme, or RNA aptamer, must be efficiently transcribed, stabilized against rapid degradation, folded correctly, and directed to the part of the cell where it can be most effective. To overcome a number of these problems we have been testing expression cassettes based on the human tRNAmet and U6 snRNA promoters, in which transcripts encoding small RNA inserts are protected against attack from the 3′ end. Transient expression in cultured cells results in 10_3_–2 × 10_7_ full-length transcripts per cell, depending partially on the promoter construct used but also on the nature of the insert RNA. 5′ γ-Phosphate methylation (capping) depended, as expected, on the inclusion of specific U6 snRNA sequences from positions +19 to +27. In situ localization of the transcripts shows that both tRNA and U6 promoter transcripts give primarily punctate nuclear patterns, and that capping of transcripts is not required for nuclear retention. Several different insert RNAs directed against HIV-1 were tested by cotransfection with HIV-1 provirus and assay for subsequent viral reverse transcriptase production. These include antisense RNA, hairpin and hammerhead ribozymes, and RNA ligands (aptamers) for Tat and Rev RNA binding proteins. Results show that Rev-binding RNAs efficiently block HIV-1 gene expression, whereas other RNAs have little or no effect when expressed in these cassettes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Department of Biological Chemistry, University of Michigan, Ann Arbor, MI, USA
PD Good, AJ Krikos & DR Engelke - Department of Pediatrics, City of Hope, Duarte, CA, USA
SXL Li & JA Zaia - Center for Molecular Biology and Gene Technology, Loma Linda University, Loma Linda, CA, USA
E Bertrand, NS Lee & JJ Rossi - Department of Chemistry, Indiana University, Bloomington, IN, USA
L Giver & A Ellington
Authors
- PD Good
You can also search for this author inPubMed Google Scholar - AJ Krikos
You can also search for this author inPubMed Google Scholar - SXL Li
You can also search for this author inPubMed Google Scholar - E Bertrand
You can also search for this author inPubMed Google Scholar - NS Lee
You can also search for this author inPubMed Google Scholar - L Giver
You can also search for this author inPubMed Google Scholar - A Ellington
You can also search for this author inPubMed Google Scholar - JA Zaia
You can also search for this author inPubMed Google Scholar - JJ Rossi
You can also search for this author inPubMed Google Scholar - DR Engelke
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Good, P., Krikos, A., Li, S. et al. Expression of small, therapeutic RNAs in human cell nuclei.Gene Ther 4, 45–54 (1997). https://doi.org/10.1038/sj.gt.3300354
- Received: 25 June 1996
- Accepted: 30 September 1996
- Issue Date: 01 January 1997
- DOI: https://doi.org/10.1038/sj.gt.3300354